You are here: Industry Insights > EBITDA

News List

Lincoln Pharmaceuticals reports standalone net profit of Rs 17.38 crores in Q1FY22 expresspharma
August 11, 2021
EBITDA for Q1FY22 was reported at Rs 26.31 crores, a rise of 17.37 per cent as compared to EBITDA of Rs 22.42 crores in Q1FY21.
Gerresheimer’s global pharma business develops well during COVID-19 pandemic expresspharma
July 16, 2020
Gerresheimer generated revenues of EUR 363 million in the second quarter of 2020, marking 4.6 per cent organic growth in the core business compared to the same quarter of the prior year.
Abbott India Q4FY20 performance hit by COVID 19 impact: ICICI Securities expresspharma
June 10, 2020
“We have reduced our revenue and EPS estimates for FY21E-FY22E by 4-5 per cent and 12-14 per cent to factor COVID-19 impact and lower other income,” commented the capital market company on the pharma company’s financial performance for the quarter.
Amneal to Acquire Majority Interest in AvKARE americanpharmaceuticalreview
December 17, 2019
Amneal Pharmaceuticals and AvKARE have entered into a definitive agreement under which Amneal will acquire a 65.1% majority interest in AvKARE and its related affiliate doing business ...